Acetazolamide for Treatment Resistant Schizophrenia
Phase 1/2
60
about 4.9 years
18–55
1 site in PA
About this study
Researchers are testing whether acetazolamide helps people with schizophrenia who haven't responded well to other treatments. It involves comparing acetazolamide to a placebo (an inactive pill). The trial will last about 1793 days and involve approximately 60 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Acetazolamide
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
acetazolamide
injection, intravenous
Primary: Change in positive symptoms
Secondary: Cognition, Measure of satisfaction with one's Quality of Life (Quality of Life Scale/QOLS)
Psychiatry / Mental Health